drugset / Trial / NCT02941419

Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis

NCT02941419

Phase 1/2 Completed 10 enrolled University of Jordan
NaSingle-groupOpen-labelTreatment

Summary

Induction of autologous angiogenesis in patients with critical limb ischemia using platelet lysate.

Timeline

Start
2013-03-05
Primary completion
2016-09-15
Completion
2017-02-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Lysate Unknown Intramuscular

Indications